Guardant Health director exercises 154 RSUs
Guardant Health, Inc. director Steve E. Krognes exercised restricted stock units into common stock in a routine compensation-related transaction.
Rhea-AI Filing Summary
Guardant Health, Inc. director Steve E. Krognes exercised restricted stock units into common stock in a routine compensation-related transaction. On April 30, 2026, 154 common shares were acquired upon RSU vesting, bringing his direct common stock holdings to 19,362 shares.
The RSUs originated from an award granted on August 9, 2022, with 25% vesting on June 30, 2023 and the remaining 75% vesting in substantially equal monthly installments over three years. After this vesting event, he holds 309 restricted stock units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
154 shares exercised/converted
Exercise
2 txns
Insider
Krognes Steve E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 154 | $0.00 | $0.00 |
| Exercise | Common Stock | 154 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 309 contracts (Direct);
Common Stock — 19,362 shares (Direct)
Footnotes (2)
- F1. This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and as to the remaining 75% of the shares subject to such award vests in substantially equal installments each month during the three-year period thereafter.
- F2. Not applicable for Restricted Stock Units.
Key Figures
RSUs exercised: 154 shares
Common shares held after transaction: 19,362 shares
RSUs remaining: 309 units
+3 more
6 metrics
RSUs exercised
154 shares
Restricted Stock Units converted to common stock on April 30, 2026
Common shares held after transaction
19,362 shares
Direct Guardant Health common stock holdings after RSU exercise
RSUs remaining
309 units
Restricted Stock Units directly held after April 30, 2026 vesting
Exercise transactions
1 exercise, 154 shares
Transaction summary exerciseCount and exerciseShares
RSU grant date
August 9, 2022
Original restricted stock unit award grant date
Initial vesting tranche
25% of award
Vested on June 30, 2023 from August 9, 2022 RSU grant
Key Terms
Restricted Stock Units, Exercise or conversion of derivative security, Form 4
3 terms
Restricted Stock Units financial
"This represents a restricted stock unit award granted on August 9, 2022."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) director Steve Krognes report in this Form 4?
Steve Krognes reported exercising restricted stock units into common stock. On April 30, 2026, 154 Guardant Health shares were acquired from RSU vesting, reflecting routine equity compensation rather than an open-market purchase or sale.
How many restricted stock units does Steve Krognes still hold at Guardant Health (GH)?
Following the April 30, 2026 vesting event, Steve Krognes directly holds 309 restricted stock units. These RSUs continue to vest according to the original award schedule granted on August 9, 2022, subject to the plan’s terms.
Was this Guardant Health Form 4 a stock purchase or sale by Steve Krognes?
The Form 4 reflects an exercise of restricted stock units, not an open-market buy or sell. Code “M” indicates a derivative exercise or conversion, where 154 RSUs converted into common stock at a stated price of $0.00 per share.
What is the vesting schedule for Steve Krognes’ Guardant Health RSU award?
The RSU award was granted on August 9, 2022. Twenty-five percent vested on June 30, 2023, with the remaining 75% scheduled to vest in substantially equal monthly installments over the following three-year period, subject to applicable conditions.
Does this Guardant Health Form 4 indicate any tax withholding or sales?
No tax withholding or sale transactions are reported in this Form 4. The transaction summary shows one derivative exercise for 154 shares and no sell, gift, or tax withholding entries, indicating a straightforward RSU-to-share conversion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
